Creative Financial Designs’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7K Buy
368
+16
+5% +$869 ﹤0.01% 1386
2026
Q1
$22.1K Sell
352
-15
-4% -$1.2K ﹤0.01% 1173
2025
Q4
$35K Sell
367
-30
-8% -$2.94K ﹤0.01% 994
2025
Q3
$38.8K Buy
397
+30
+8% +$3.11K ﹤0.01% 943
2025
Q2
$39.4K Sell
367
-28
-7% -$2.83K ﹤0.01% 941
2025
Q1
$39.8K Buy
395
+10
+3% +$1.01K ﹤0.01% 897
2024
Q4
$34.4K Sell
385
-26
-6% -$2.29K ﹤0.01% 913
2024
Q3
$34.4K Sell
411
-270
-40% -$21.3K ﹤0.01% 895
2024
Q2
$52.4K Hold
681
﹤0.01% 736
2024
Q1
$46.6K Buy
681
+324
+91% +$20.8K ﹤0.01% 744
2023
Q4
$20.6K Buy
+357
New +$19.1K ﹤0.01% 912
2021
Q4
Sell
-1,347
Closed -$58K 1233
2021
Q3
$58K Sell
1,347
-325
-19% -$14.4K 0.01% 573
2021
Q2
$71K Buy
1,672
+325
+24% +$13.7K 0.01% 516
2021
Q1
$52K Hold
1,347
0.01% 552
2020
Q4
$48K Sell
1,347
-88
-6% -$3.17K 0.01% 518
2020
Q3
$55K Buy
1,435
+156
+12% +$6.01K 0.01% 446
2020
Q2
$45K Buy
+1,279
New +$46.1K 0.01% 434

Other funds holding BSX

Creative Financial Designs's BSX Position: Q2 2026 in Review

Creative Financial Designs increased its Boston Scientific (BSX) stake by 4.5% in Q2 2026, buying an estimated $869 and bringing the position to 368 shares worth $15.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Creative Financial Designs first reported a position in BSX in Q2 2020 and has held it in 17 quarters since. The position peaked at $71K in Q2 2021. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Creative Financial Designs held 368 shares of Boston Scientific worth $15.7K as of Q2 2026.
  • Creative Financial Designs bought 16 Boston Scientific shares in Q2 2026, an estimated $869.
  • Boston Scientific made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #1386 holding.
  • Creative Financial Designs first reported a position in Boston Scientific in Q2 2020 and has held it in 17 quarters since.
  • Creative Financial Designs's Boston Scientific position peaked at $71K in Q2 2021.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.